Pharmaceutical Packaging and Labeling Services

The contract entails the compliant packaging and labeling of Adenosine Injection in accordance with stringent requirements set by the Defense Logistics Agency, ensuring all materials meet federal standards for pharmaceutical distribution. This includes the application of durable block-printed labels that feature complete traceability elements and mandatory contract identifiers to support accountability and inventory management across the Department of Defense supply chain. The work must be performed to exact specifications to ensure regulatory compliance, safety, and operational readiness for military medical use. This is a subcontract under the NAICS code 325991, categorized as a pharmaceutical manufacturing and packaging service, awarded through the Defense Logistics Agency’s procurement system. While no specific location is designated for performance, the work is expected to support DLA's national defense medical logistics mission. The contract was posted in July 2026 and is accessible via the DIBBS platform under reference SPE2DX25D8022, with a delivery identification of SPE2D926F7386, indicating it is an active award tied to a specific fulfillment task within the DOD’s pharmaceutical supply network.